Deciphera Pharmaceuticals (DCPH) Tops Q3 EPS by 3c

Deciphera Pharmaceuticals (NASDAQ: DCPH) reported Q3 EPS of ($0.58), $0.03 better than the analyst estimate of ($0.61). Revenue for the quarter came in at $43.31 million versus the consensus estimate of $39.44 million.

For earnings history and earnings-related data on Deciphera Pharmaceuticals (DCPH) click here.

You May Also Be Interested In

• Investing.com’s stocks of the week
• Muthoot Finance Ltd (MUTH:IN) PT Lowered to INR4,030 at BofA Securities
• Regency Centers (REG) Tops Q2 EPS by 2c